« Back
Home /
Dovitinib lactate hydrate

Dovitinib lactate hydrate

Item no.	TMO-T6479-200mg
Manufacturer	TargetMol
CASRN	915769-50-5
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 50 mg 5 mg
Category	Oncology Reagents & Chemicals Molecules By Organ Colorectal Cancer
Type	Molecules
Specific against	other
Smiles	O.CC(O)C(O)=O.CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Dovitinib (TKI258) Lactate,Dovitinib Lactate,TKI258
Shipping Condition	Cool pack
Available
Manufacturer - Targets	c-Kit\|\|\|PDGFR\|\|\|FGFR\|\|\|VEGFR\|\|\|FLT
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	482.51
Description	Dovitinib lactate hydrate (TKI258) is the Lactate of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGFR1 and HER2. Phase 4.
Pathways	Angiogenesis\|\|\|Tyrosine Kinase/Adaptors
Receptor	c-Kit; FGFR1; FGFR3; FLT3; VEGFR3/FLT4

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T6479-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question